What is Mineralys Therapeutics, Inc.'s net change in cash?

Mineralys Therapeutics, Inc. (MLYS) reported net change in cash of -$60.14M in Q1 2026.

How has Mineralys Therapeutics, Inc.'s net change in cash changed year-over-year?

Mineralys Therapeutics, Inc.'s net change in cash decreased by 218.1% year-over-year, from $50.92M to -$60.14M.

What does net change in cash mean?

Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

Mineralys Therapeutics, Inc. MLYS Net Change in Cash

Net Change in Cash at other companies

MannkindMNKD

-$22.05M-2,361%

Aurinia PharmaceuticalsAUPH

-$39.21M-131%

Crinetics PharmaceuticalsCRNX

$12.81M+108%

Stoke Therapeutics, Inc.STOK

$74.44M-49.3%

Kiniksa Pharmaceuticals International, plcKNSA

$24.36M+192%

CytokineticsCYTK

$7.32M+135%

Other financials

Income statement

See full

Operating income-$45.3M-2.0%

Net income-$39.3M+6.8%

EPS (diluted)-$0.47+40.5%

Balance sheet

See full

Cash & equivalents$1.2M-14.6%

Total equity$638.1M+86.8%

Total assets$652.9M+83.9%

Cash flow

See full

Operating cash flow-$39.5M+13.2%

CapEx$15.0K—

Free cash flow-$37.9M+43.3%

Valuation

See full

Market cap$2.27B+124%

Returns & leverage

See full

Return on equity-31%-9.6pp

Current ratio44.3×+17.8×

Where this comes from

Reported directly by Mineralys Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: Mineralys Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Mineralys Therapeutics, Inc.'s net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Mineralys Therapeutics, Inc.'s net change in cash?: Mineralys Therapeutics, Inc. (MLYS) reported net change in cash of -$60.14M in Q1 2026.
How has Mineralys Therapeutics, Inc.'s net change in cash changed year-over-year?: Mineralys Therapeutics, Inc.'s net change in cash decreased by 218.1% year-over-year, from $50.92M to -$60.14M.
What does net change in cash mean?: Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.